NCT02393248 2023-01-06Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Incyte CorporationPhase 1/2 Terminated201 enrolled 71 charts
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT00002854 2015-08-26High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerCity of Hope Medical CenterPhase 1 Completed33 enrolled
NCT00010023 2011-04-05Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsNYU Langone HealthPhase 1 Completed